Medicare is offering beneficiaries access to popular obesity drugs for a $50 monthly copay. Patients have to meet certain criteria to qualify. It's a temporary measure that runs through 2027.
Copyright 2026 NPR
A service of Salisbury University and University of Maryland Eastern Shore
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Support Provided By: (Sponsored Content)